K202101: GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K202101 (GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te, cleared 2021-12-29 for Accriva Diagnostics, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K202101
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK202101
Cleared Device Trade / Generic NameGEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te
FDA Applicant on FilingAccriva Diagnostics, Inc.
FDA 3-Letter Product ClassificationProduct Code JPA
FDA Substantial Equivalence Decision Date2021-12-29
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Accriva Diagnostics, Inc., compare peer devices under FDA Product Code JPA, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.